Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Electrophysiology & Arrhythmia | April 2020
Tuesday, April 14, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

Top Stories

Hospital testing hydroxychloroquine on coronavirus patients notes serious side effects

A French hospital testing the effectiveness of hydroxychloroquine on COVID-19 patients had to immediately stop testing on one patient due to the risk of significant cardiac side effects.

READ MORE >
Covid coronavirus
Share on Twitter Share on Facebook Share on Linkedin

Hospital testing hydroxychloroquine on coronavirus patients notes serious side effects

Share on Twitter Share on Facebook Share on Linkedin
Covid coronavirus
A French hospital testing the effectiveness of hydroxychloroquine on COVID-19 patients had to immediately stop testing on one patient due to the risk of significant cardiac side effects.
READ MORE >

Warfarin use boosts risk of hemorrhagic stroke among end-stage kidney patients with AFib

Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published in JAMA Network Open. It does, however, lead to an increased risk of hemorrhagic stroke.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Warfarin use boosts risk of hemorrhagic stroke among end-stage kidney patients with AFib

Share on Twitter Share on Facebook Share on Linkedin
stroke
Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published in JAMA Network Open. It does, however, lead to an increased risk of hemorrhagic stroke.
READ MORE >

Can smartphones diagnose AFib?

Smartphone cameras could play an important role in the diagnosis of AFib, according to new findings published in JAMA Network Open.

READ MORE >
Texting
Share on Twitter Share on Facebook Share on Linkedin

Can smartphones diagnose AFib?

Share on Twitter Share on Facebook Share on Linkedin
Texting
Smartphone cameras could play an important role in the diagnosis of AFib, according to new findings published in JAMA Network Open.
READ MORE >

For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

For TAVR patients with AFib, antiplatelet medication linked to poorer outcomes

Share on Twitter Share on Facebook Share on Linkedin
Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe.
READ MORE >

Featured Articles

Nearly half of all serious cardiac events among pregnant women with heart disease are preventable

A significant number of life-threatening complications in pregnant women with heart disease could be prevented altogether, according to new findings published by the Journal of the American College of Cardiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Nearly half of all serious cardiac events among pregnant women with heart disease are preventable

Share on Twitter Share on Facebook Share on Linkedin
A significant number of life-threatening complications in pregnant women with heart disease could be prevented altogether, according to new findings published by the Journal of the American College of Cardiology.
READ MORE >

E-cigarette interferes with user’s implantable cardiac device, creating potential for ‘fatal consequences’

A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

E-cigarette interferes with user’s implantable cardiac device, creating potential for ‘fatal consequences’

Share on Twitter Share on Facebook Share on Linkedin
A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a new analysis published in HeartRhythm Case Reports.
READ MORE >

How one hospital is perfecting mechanical CPR in the ED

On a biweekly basis, researchers and physicians at the Feinstein Institutes for Medical Research and North Shore University Hospital in New York gather to watch footage of patient resuscitations.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How one hospital is perfecting mechanical CPR in the ED

Share on Twitter Share on Facebook Share on Linkedin
On a biweekly basis, researchers and physicians at the Feinstein Institutes for Medical Research and North Shore University Hospital in New York gather to watch footage of patient resuscitations.
READ MORE >

Ablation continues to benefit patients with concomitant HF, AFib

A new analysis of the CASTLE-AF trial has found that catheter ablation for AFib remains effective in a much larger group of heart failure patients, cementing evidence first presented in early 2018.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Ablation continues to benefit patients with concomitant HF, AFib

Share on Twitter Share on Facebook Share on Linkedin
A new analysis of the CASTLE-AF trial has found that catheter ablation for AFib remains effective in a much larger group of heart failure patients, cementing evidence first presented in early 2018.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme